Friday, November 30, 2018 10:18:04 AM
List of Applicants Selected for the Challenge
The FDA received an overwhelming response to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder. Over 250 applications were received from medical device developers large and small. After careful review using an established set of criteria, eight challenge participants have been selected. The medical devices from the selected participants include those intended to predict the risk of opioid used disorder (OUD), detect opioid overdose, dispense medication and provide pain treatment alternatives to opioids.
Company
Product Name
Category
Algomet Rx, Inc.
Rapid Drug Screen
Monitoring
Avanos
Withheld Per Company Request
Other
Brainsway, Ltd
Brainsway Deep Transcranial Magnetic Stimulation (DTMS) Device
Opioid Use Disorder Therapy
CognifiSense, Inc.
Virtual Reality Neuropsychological Therapy (VRNT)
Pain Therapy
iPill Dispenser
iPill Dispenser
Medication Dispensing
Masimo Corporation
Withheld Per Company Request
Overdose Therapy
Milliman
Opioid Prediction Service
Diagnostic
ThermoTek, Inc.
NanoThermTM and VascuThermTM Systems
Pain Therapy
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM